Search Results - "Nienhuis, Mark B"

Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis by Nienhuis, Mark B., Ottervanger, Jan Paul, Bilo, Henk J.G., Dikkeschei, Bert D., Zijlstra, Felix

“…Background: Although the prognostic importance of troponin in patients with anacute coronary syndrome is clear, the significance of troponin elevation after…”
Get full text

Comparison of Frequency of Periprocedural Myocardial Infarction in Patients With and Without Diabetes Mellitus to Those With Previously Unknown but Elevated Glycated Hemoglobin Levels (from the TWENTE Trial) by Tandjung, Kenneth, MD, van Houwelingen, K. Gert, MD, Jansen, Hanneke, MD, PhD, Basalus, Mounir W.Z., MD, Sen, Hanim, MD, Löwik, Marije M., PhD, Stoel, Martin G., MD, Louwerenburg, J. (Hans) W., MD, de Man, Frits H.A.F., MD, PhD, Linssen, Gerard C.M., MD, PhD, Nijhuis, Rogier, MD, Nienhuis, Mark B., MD, PhD, van der Palen, Job, PhD, Stolk, Ronald P., MD, PhD, von Birgelen, Clemens, MD, PhD

“…In patients without a history of diabetes mellitus, increased levels of glycated hemoglobin (HbA1c) are associated with higher cardiovascular risk. The…”
Get full text

Prognostic importance of creatine kinase and creatine kinase–MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction by Nienhuis, Mark B., MD, Ottervanger, Jan Paul, MD, PhD, de Boer, Menko-Jan, MD, PhD, Dambrink, Jan-Henk E., MD, PhD, Hoorntje, Jan C.A., MD, PhD, Gosselink, A.T. Marcel, MD, PhD, Suryapranata, Harry, MD, PhD, van't Hof, Arnoud W.J., MD, PhD

“…Background Although the prognostic significance of creatine kinase (CK) and creatine kinase–MB (CK-MB) after myocardial infarction has been established after…”
Get full text

DUrable polymer-based sTent CHallenge of Promus ElemEnt versus ReSolute integrity (DUTCH PEERS): Rationale and study design of a randomized multicenter trial in a Dutch all-comers population by Tandjung, Kenneth, MD, Basalus, Mounir W.Z., MD, Sen, Hanim, MD, Jessurun, Gillian A.J., MD, PhD, Danse, Peter W., MD, PhD, Stoel, Martin, MD, Linssen, Gerard C.M., MD, Derks, Anita, MD, van Loenhout, Ton T., MD, Nienhuis, Mark B., MD, PhD, Hautvast, Raymond W.M., MD, PhD, von Birgelen, Clemens, MD, PhD

“…Background Drug-eluting stents (DES) are increasingly used for the treatment of coronary artery disease. An optimized DES performance is desirable to…”
Get full text

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents by Tandjung, Kenneth, MD, Sen, Hanim, MD, Lam, Ming Kai, MD, Basalus, Mounir W.Z., MD, Louwerenburg, J. (Hans) W., MD, Stoel, Martin G., MD, van Houwelingen, K. Gert, MD, de Man, Frits H.A.F., MD, PhD, Linssen, Gerard C.M., MD, PhD, Saïd, Salah A.M., MD, PhD, Nienhuis, Mark B., MD, PhD, Löwik, Marije M., PhD, Verhorst, Patrick M.J., MD, PhD, van der Palen, Job, PhD, von Birgelen, Clemens, MD, PhD

“…Objectives The aim of this study was to assess the safety and efficacy of the implantation of Resolute zotarolimus-eluting stents (ZES) (Medtronic Inc., Santa…”
Get full text

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial by von Birgelen, Clemens, PhD, Sen, Hanim, MD, Lam, Ming Kai, MD, Danse, Peter W, PhD, Jessurun, Gillian A J, PhD, Hautvast, Raymond W M, PhD, van Houwelingen, Gert K, MD, Schramm, Alexander R, MD, Gin, R Melvyn Tjon Joe, MD, Louwerenburg, Johannes W, MD, de Man, Frits H A F, PhD, Stoel, Martin G, PhD, Löwik, Marije M, PhD, Linssen, Gerard C M, PhD, Saïd, Salah A M, PhD, Nienhuis, Mark B, PhD, Verhorst, Patrick M J, PhD, Basalus, Mounir W Z, PhD, Doggen, Carine J M, PhD, Tandjung, Kenneth, MD

“…Summary Background Third-generation, permanent-polymer-based drug-eluting stents with novel, flexible designs might be more easily delivered than previous…”
Get full text

Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction by Nienhuis, Mark B, Ottervanger, Jan Paul, Dambrink, Jan-Henk E, de Boer, Menko-Jan, Hoorntje, Jan CA, Gosselink, AT Marcel, Suryapranata, Harry, van ʼt Hof, Arnoud WJ

“…OBJECTIVEAlthough infarct location may predict prognosis after primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction,…”
Get full text

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents: 2-Year Follow-Up of the Randomized TWENTE Trial by TANDJUNG, Kenneth, SEN, Hanim, NIENHUIS, Mark B, LÖWIK, Marije M, VERHORST, Patrick M. J, DER PALEN, Job Van, VON BIRGELEN, Clemens, KAI LAM, Ming, BASALUS, Mounir W. Z, LOUWERENBURG, J. (hans) W, STOEL, Martin G, HOUWELINGEN, K. Gert Van, DE MAN, Frits H. A. F, LINSSEN, Gerard C. M, SAID, Salah A. M

“…The aim of this study was to assess the safety and efficacy of the implantation of Resolute zotarolimus-eluting stents (ZES) (Medtronic Inc., Santa Rosa,…”
Get full text

Pre-treatment with clopidogrel and postprocedure troponin elevation after elective percutaneous coronary intervention by Nienhuis, Mark B, Ottervanger, Jan Paul, Miedema, Kor, Suryapranata, Harry, de Boer, Menko-Jan, Dambrink, Jan-Henk E, Hoorntje, Jan C A, van 't Hof, Arnoud W J, Gosselink, Marcel, Zijlstra, Felix

“…Elevated troponin after elective percutaneous coronary intervention (PCI) has been associated with a worse prognosis. Pretreatment with clopidogrel may be…”
Get more information

Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial by Lam, Ming Kai, Tandjung, Kenneth, Sen, Hanim, Basalus, Mounir W Z, van Houwelingen, K Gert, Stoel, Martin G, Louwerenburg, Johannes W, Linssen, Gerard C M, Saïd, Salah A M, Nienhuis, Mark B, de Man, Frits H A F, van der Palen, Job, von Birgelen, Clemens

“…To investigate the prognostic value of coronary dominance for various adverse clinical events following the implantation of drug-eluting stents. We assessed…”
Get full text

TCT-188 Two-Year Clinical Outcome of Patients With Bifurcation Lesions Treated With Second-generation Zotarolimus-Eluting Resolute Stents and Everolimus-Eluting Xience V Stents in the Randomized TWENTE Trial by Tandjung, Kenneth, Sen, Hanim, Lam, Ming Kai, Löwik, Marije M, van Houwelingen, Gert, Stoel, Martin G, Louwerenburg, Hans W, de Man, F, Linssen, Gerard C, Nijhuis, Rogier, Nienhuis, Mark B, von Birgelen, Clemens

Get full text

TCT-172 Clinical Outcome of Complex Patients Treated With Second-Generation Zotarolimus-Eluting Resolute vs. Everolimus-Eluting Xience V Stents: Insight From 2-Year Follow-up of TWENTE by Sen, Hanim, Tandjung, Kenneth, Lam, Ming Kai, Basalus, Mounir W, Stoel, Martin G, de Man, F, Louwerenburg, Hans W, van Houwelingen, Gert, Linssen, Gerard C, Nienhuis, Mark B, van der Palen, Job, von Birgelen, Clemens

Get full text

TCT-342 Risk and Consequences of Periprocedural Myocardial Infarction Following Off-Label Use of Second Generation Drug-Eluting Stents: Two-Year Follow-up in the TWENTE Trial by Sen, Hanim, Lam, Ming Kai, Tandjung, Kenneth, Basalus, Mounir W, Stoel, Martin G, van Houwelingen, Gert, de Man, F, Louwerenburg, Hans W, Linssen, Gerard C, Nienhuis, Mark B, Löwik, Marije M, van der Palen, Job, von Birgelen, Clemens

Get full text

TCT-349 Predictive Value of the Syntax Score for the Occurrence of Periprocedural Myocardial Infarction in the TWENTE Trial by Tandjung, Kenneth, Lam, Ming Kai, Sen, Hanim, Basalus, Mounir W, van Houwelingen, Gert, Stoel, Martin G, Louwerenburg, Hans W, de Man, F, Linssen, Gerard C, Nienhuis, Mark B, Nijhuis, Rogier, von Birgelen, Clemens

Get full text

Prognostic importance of elevated troponin T and creatine kinase after elective angioplasty by Nienhuis, Mark B, Ottervanger, Jan Paul

Get full text

Incidence of periprocedural myocardial infarction following stent implantation: Comparison between first- and second-generation drug-eluting stents by Tandjung, Kenneth, Basalus, Mounir W.Z., Muurman, Esther, Louwerenburg, Hans W., van Houwelingen, K. Gert, Stoel, Martin G., de Man, Frits H.A.F., Jansen, Hanneke, Huisman, Jennifer, Linssen, Gerard C.M., Droste, Herman T., Nienhuis, Mark B., von Birgelen, Clemens

“…Background: First‐ and second‐generation drug‐eluting stents (DES) differ in coating materials, which may influence the incidence of periprocedural myocardial…”
Get full text

Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and XIENCE V drug-eluting stents by SEN, Hanim, TANDJUNG, Kenneth, NIENHUIS, Mark B, VERHORST, Patrick M. J, VAN DER PALEN, Job, VON BIRGELEN, Clemens, BASALUS, Mounir W. Z, LÖWIK, Marije M, VAN HOUWELINGEN, Gert K, STOEL, Martin G, LOUWERENBURG, Hans W, DE MAN, Frits H. A. F, LINSSEN, Gerard C. M, NIJHUIS, Rogier

“…The TWENTE trial recently enrolled more than 80% of all eligible patients, who were randomised to zotarolimus-eluting Resolute or everolimus-eluting XIENCE V…”
Get full text

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial by Sen, Hanim, Lam, Ming Kai, Tandjung, Kenneth, Basalus, Mounir W Z, de Man, Frits H A F, Louwerenburg, J Hans W, Stoel, Martin G, van Houwelingen, Gert K, Löwik, Marije M, Linssen, Gerard C M, Saïd, Salah A M, Nienhuis, Mark B, Verhorst, Patrick M J, van der Palen, Job, von Birgelen, Clemens

“…Drug-eluting stents (DES) were first used on-label - in simple patients with low clinical risk and easily accessible lesions. Currently, DES are increasingly…”
Get full text

Prognostic importance of troponin T and creatine kinase after elective angioplasty by Nienhuis, Mark B, Ottervanger, Jan Paul, Dikkeschei, Bert, Suryapranata, Harry, de Boer, Menko-Jan, Dambrink, Jan-Henk E, Hoorntje, Jan C.A, van 't Hof, Arnoud W.J, Gosselink, Marcel, Zijlstra, Felix

“…Abstract Background The prognostic importance of elevated cardiac enzymes after elective percutaneous coronary intervention has been debated. Therefore, we…”
Get full text

Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarction by Rasoul, Saman, Nienhuis, Mark B, Ottervanger, Jan Paul, Slingerland, Robbert J, de Boer, Menko-Jan, Dambrink, Jan-Henk E, Ernst, Nicolette M, Hoorntje, Jan C A, Gosselink, A T Marcel, Suryapranata, Harry, Zijlstra, Felix, van 't Hof, Arnoud W J

“…In patients with ST-segment elevation acute myocardial infarction (STEMI), elevated cardiac troponin T (cTnT) on admission is associated with poorer outcomes…”
Get more information